The effect of age on serum creatinine levels in an aging population: relevance to vascular surgery.

Background And Aim: Serum creatinine is commonly used to assess and monitor renal function in the management of abdominal aortic aneurysm with endoluminal grafting, and for intervention of renal artery occlusive disease. The majority of patients selected for these procedures are elderly and serum creatinine is used post-operatively to monitor renal function. There is a need to adjust the serum creatinine concentration for age to determine the changes that might be due to the procedure: especially with endoluminal grafting using transrenal manipulation and fixation, and procedures involving interventions directly on the renal arteries.

Genotype-phenotype studies of six novel LPL mutations in Chinese patients with hypertriglyceridemia.

We screened 160 unrelated Chinese hypertriglyceridemic subjects for sequence alterations in the promoter and the 10 exons of the lipoprotein lipase (LPL) gene. We identified one reported mutation (L252R), one common polymorphism (S447X), and six novel mutations: V181I, C283Y, S298R and S338F (found in single individuals), L252V (in two individuals), and A71T (in three individuals). Screening of family members of the above probands revealed a total of 19 mutation carriers, most of whom, though not all, displayed reduced LPL activity and mass when compared to normolipidemic control subjects.

Compound heterozygosity of Leu252Val and Leu252Arg causing lipoprotein lipase deficiency in a chinese patient with hypertriglyceridemia.

Background: We investigated lipoprotein lipase (LPL) gene mutations in a Chinese male with severe hypertriglyceridemia and recurrent pancreatitis.

Methods: We screened for LPL sequence mutation in the LPL gene in this patient, his relatives and 160 unrelated hypertriglyceridaemic subjects. We determined the postheparin plasma LPL activity of subjects carrying a LPL mutation and studied the in vitro expression of mutant LPL in COS-1 cells.

Mutations in the low-density lipoprotein receptor gene in Chinese familial hypercholesterolemia patients.

It has been reported that in China, patients with heterozygous familial hypercholesterolemia (FH) may go unrecognized because they do not have xanthomata or premature coronary heart disease and their LDL cholesterol levels are lower than those in their Western counterparts. However, in the Chinese patients in Hong Kong, heterozygous FH appears to manifest in a way similar to that seen in Western countries or Japan. We studied sequence variations in the promoter and coding regions of the 18 exons of the LDL receptor gene in 30 Chinese FH patients.